Recently, Sinovac Biotech, Hualan Biological Engineering, Inc., Peking Biological Products Institute Co., Ltd., and Jindike Biological Engineering Co., Ltd. have successively lowered the prices of their quadrivalent influenza vaccines, with the average price reduction of the products of several companies reaching around 30%. It is reported that many regions have already formulated the first batch of procurement plans for influenza vaccines for the new year in the second quarter of each year. Major vaccine companies adjust the prices of quadrivalent influenza vaccines at this point, with many considering "pricing for volume and seizing the market".
四价流感疫苗平均降价3成
The quadrivalent influenza vaccine has decreased in price by an average of 30%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.